Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa: A cross-sectional study
Research output: Contribution to journal › Letter › Research › peer-review
Standard
Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa : A cross-sectional study. / Omari, N.; Simonsen, S.; Gluud, L. L.; Martin, H. M.; Trelle, M. B.; Jemec, G. B.; Skov, L.; Näslund-Koch, C.
In: Journal of the European Academy of Dermatology and Venereology, 2024.Research output: Contribution to journal › Letter › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa
T2 - A cross-sectional study
AU - Omari, N.
AU - Simonsen, S.
AU - Gluud, L. L.
AU - Martin, H. M.
AU - Trelle, M. B.
AU - Jemec, G. B.
AU - Skov, L.
AU - Näslund-Koch, C.
N1 - Funding Information: This study was supported by the Ellab Foundation, the LEO Foundation (grant number [LF\u2010ST\u201021\u2010500002]) and Copenhagen University Hospital \u2013 Herlev and Gentofte Hospital, Denmark. Siemens Healthcare provided the ELF test kits.
PY - 2024
Y1 - 2024
N2 - Patients with hidradenitis suppurativa (HS) have higher prevalence of various concomitant disorders such as obesity, diabetes, metabolic syndrome and cardiovascular disease, compared to the general population.1 Recently, metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD),2 was added to the list.3 However, previous studies have focused on the presence of harmless liver steatosis rather on the presence of advanced fibrosis, which poses a greater clinical concern due to its high morbidity and mortality.4 In addition, previous studies lack data regarding important confounders such as alcohol consumption and severity of HS.
AB - Patients with hidradenitis suppurativa (HS) have higher prevalence of various concomitant disorders such as obesity, diabetes, metabolic syndrome and cardiovascular disease, compared to the general population.1 Recently, metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD),2 was added to the list.3 However, previous studies have focused on the presence of harmless liver steatosis rather on the presence of advanced fibrosis, which poses a greater clinical concern due to its high morbidity and mortality.4 In addition, previous studies lack data regarding important confounders such as alcohol consumption and severity of HS.
U2 - 10.1111/jdv.20110
DO - 10.1111/jdv.20110
M3 - Letter
C2 - 38764439
AN - SCOPUS:85193602333
JO - Journal of the European Academy of Dermatology and Venereology
JF - Journal of the European Academy of Dermatology and Venereology
SN - 0926-9959
ER -
ID: 393842739